Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study

Background. Surgery for GI dysmotility is limited to those with severe refractory disease. Though effective, use of serotonergic promotility drugs has been restricted in Canada due to adverse events. We aimed to investigate utilization of promotility serotonergic drugs in patients under consideratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kidane, Biniam, Manji, Farouq, Lam, Jennifer, Taylor, Brian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904120/
https://www.ncbi.nlm.nih.gov/pubmed/27313955
http://dx.doi.org/10.1155/2016/5797804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904120/
https://www.ncbi.nlm.nih.gov/pubmed/27313955
http://dx.doi.org/10.1155/2016/5797804

Ejemplares similares